Beam Therapeutics (BEAM) News Today $25.75 +0.16 (+0.63%) Closing price 10/3/2025 04:00 PM EasternExtended Trading$26.08 +0.32 (+1.26%) As of 09:13 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BEAM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period Beam Therapeutics Scores Relative Strength Rating Upgrade; Hits Key BenchmarkOctober 4 at 11:38 AM | msn.comBeam Therapeutics Shows Rising Price Performance With Jump To 81 RS RatingOctober 1, 2025 | msn.comAnalysts Set Beam Therapeutics Inc. (NASDAQ:BEAM) PT at $46.40September 29, 2025 | americanbankingnews.comVoya Investment Management LLC Has $686,000 Holdings in Beam Therapeutics Inc. $BEAMSeptember 26, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Given Consensus Recommendation of "Buy" by AnalystsSeptember 26, 2025 | marketbeat.comPeregrine Investment Management Inc. Increases Stock Holdings in Beam Therapeutics Inc. $BEAMSeptember 24, 2025 | marketbeat.comIs Beam Therapeutics Gaining or Losing Market Support?September 23, 2025 | benzinga.comCathie Wood’s ARK Investment buys 491K shares of Beam Therapeutics todaySeptember 18, 2025 | msn.comH.C. Wainwright Maintains Buy on Beam (BEAM), $80 Target on Pipeline MomentumSeptember 18, 2025 | msn.comBeam Therapeutics (NASDAQ:BEAM) Stock Price Up 6.2% - Time to Buy?September 17, 2025 | marketbeat.comRhumbline Advisers Has $2.76 Million Holdings in Beam Therapeutics Inc. $BEAMSeptember 17, 2025 | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Beam Therapeutics (NASDAQ:BEAM)September 16, 2025 | marketbeat.com43,199 Shares in Beam Therapeutics Inc. $BEAM Acquired by Jacobs Levy Equity Management Inc.September 15, 2025 | marketbeat.comWall Street Zen Downgrades Beam Therapeutics (NASDAQ:BEAM) to SellSeptember 15, 2025 | marketbeat.comBeam Therapeutics (BEAM): Assessing Valuation After Strategic Shift and Analyst Optimism on BEAM-302 ProgramSeptember 14, 2025 | finance.yahoo.comBeam Therapeutics Inc. $BEAM Shares Bought by Woodline Partners LPSeptember 13, 2025 | marketbeat.comBeam Therapeutics Inc. (BEAM) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 (Transcript)September 9, 2025 | seekingalpha.comBeam Therapeutics Inc. (BEAM) Presents At H.C. Wainwright 27th Annual Global Investment Conference TranscriptSeptember 9, 2025 | seekingalpha.comWall Street Zen Upgrades Beam Therapeutics (NASDAQ:BEAM) to HoldSeptember 8, 2025 | marketbeat.comBernstein Issues a Buy Rating on Beam Therapeutics (BEAM)September 7, 2025 | theglobeandmail.comEcoR1 Capital LLC Takes Position in Beam Therapeutics Inc. $BEAMSeptember 6, 2025 | marketbeat.comAnalysts Offer Insights on Healthcare Companies: Treace Medical Concepts (TMCI), Beam Therapeutics (BEAM) and Incyte (INCY)September 6, 2025 | theglobeandmail.comBeam Therapeutics (NASDAQ:BEAM) Trading Up 21.3% - What's Next?September 5, 2025 | marketbeat.comAllostery Investments LP Buys Shares of 92,754 Beam Therapeutics Inc. $BEAMSeptember 5, 2025 | marketbeat.comBeam Therapeutics Inc. $BEAM Shares Acquired by Redmile Group LLCSeptember 4, 2025 | marketbeat.comBeam Therapeutics Inc. $BEAM Shares Bought by Northern Trust CorpSeptember 4, 2025 | marketbeat.comBeam Therapeutics Inc. (BEAM) Presents At Citi's Biopharma Back To School Conference TranscriptSeptember 3, 2025 | seekingalpha.comBeam competitive position intact after Wave data, says Clear StreetSeptember 3, 2025 | msn.comBeam Therapeutics Inc. $BEAM Shares Sold by American Century Companies Inc.September 3, 2025 | marketbeat.comBeam Therapeutics Inc. $BEAM Shares Bought by Invesco Ltd.September 2, 2025 | marketbeat.comBeam Therapeutics Inc. (NASDAQ:BEAM) Receives Average Recommendation of "Buy" from AnalystsSeptember 2, 2025 | marketbeat.comYiheng Capital Management L.P. Sells 357,044 Shares of Beam Therapeutics Inc. $BEAMSeptember 1, 2025 | marketbeat.comRussell Investments Group Ltd. Has $571,000 Stake in Beam Therapeutics Inc. $BEAMSeptember 1, 2025 | marketbeat.comNuveen LLC Buys New Shares in Beam Therapeutics Inc. $BEAMAugust 30, 2025 | marketbeat.comBeam Therapeutics Inc. $BEAM Shares Acquired by Price T Rowe Associates Inc. MDAugust 29, 2025 | marketbeat.comCharles Schwab Investment Management Inc. Has $15.16 Million Stake in Beam Therapeutics Inc. $BEAMAugust 26, 2025 | marketbeat.comBeam Therapeutics to Participate in Upcoming September 2025 Investor ConferencesAugust 25, 2025 | globenewswire.comSwiss National Bank Acquires 34,800 Shares of Beam Therapeutics Inc. $BEAMAugust 24, 2025 | marketbeat.comVanguard Group Inc. Boosts Stock Position in Beam Therapeutics Inc. $BEAMAugust 23, 2025 | marketbeat.comCathie Wood’s ARK Investment buys 509.6K shares of Beam Therapeutics todayAugust 20, 2025 | msn.comJonesTrading Reduces the PT on Beam Therapeutics (BEAM), Keeps a Buy RatingAugust 20, 2025 | msn.comCathie Wood’s ARK Investment buys 395K shares of Beam Therapeutics todayAugust 19, 2025 | msn.comLiontrust Investment Partners LLP Reduces Stock Position in Beam Therapeutics Inc. (NASDAQ:BEAM)August 18, 2025 | marketbeat.comVestmark Advisory Solutions Inc. Has $3.02 Million Stock Holdings in Beam Therapeutics Inc. (NASDAQ:BEAM)August 18, 2025 | marketbeat.comBeam Therapeutics: A Slow-Developing StoryAugust 17, 2025 | seekingalpha.comBank of America Securities Keeps Their Buy Rating on Beam Therapeutics (BEAM)August 15, 2025 | theglobeandmail.comBeam Therapeutics (BEAM) Receives a Buy from Leerink PartnersAugust 14, 2025 | theglobeandmail.comBeam Therapeutics (BEAM) Gets a Buy from Clear StreetAugust 14, 2025 | theglobeandmail.comBeam Therapeutics' Sickle Cell Treatment Gets FDA's Generative Medicine Advanced Therapy DesignationAugust 14, 2025 | marketwatch.comBeam Therapeutics Stock Surges After FDA Grants RMAT DesignationAugust 14, 2025 | msn.com Get Beam Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BEAM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BEAM Media Mentions By Week BEAM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BEAM News Sentiment▼0.330.54▲Average Medical News Sentiment BEAM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BEAM Articles This Week▼27▲BEAM Articles Average Week Get the Latest News and Ratings for BEAM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Beam Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies CRSP News DNLI News EDIT News NTLA News TWST News VCYT News VRNA News RVMD News MRUS News GRFS News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BEAM) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThe $20 stock that could make silicon chips obsolete$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredRIP USA"The America you knew is dying in front of you" That's the urgent warning the former $200 million hedge fun...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beam Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Beam Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
